Pharmacologic Interaction Between Cannabinol and Delta9-tetrahydrocannabinol
Overview
Authors
Affiliations
The pharmacological activities of delta9-THC [(minus)-delta9-trans-tetrahydrocannabinol], CBN (Cannabinol) and mixtures of delta9-THC + CBN were studied in rabbits, rats and mice. CBN, although in general less active, mimicked the effects of delta9-THC in several pharmacological tests: corneal arreflexia in rabbits; climbing rope, open-field, irritability and aggressiveness after REM sleep deprivation in rats; catatonia, analgesia and sleeping time in mice. When the mixture delta9-THC + CBN was used, a synergistic effect occurred on most of the depressant effects. On the other hand CBN did not interfere with or slightly inhibited the excitatory effects of delta9-THC. In the one peripheral test used, CBN did not alter the delta9-THC effect.
Arnold J, Occelli Hanbury-Brown C, Anderson L, Bedoya-Perez M, Udoh M, Sharman L Neuropsychopharmacology. 2024; 50(3):586-595.
PMID: 39528623 PMC: 11736144. DOI: 10.1038/s41386-024-02018-7.
The Development of Cannabinoids as Therapeutic Agents in the United States.
Murray C, Gannon B, Winsauer P, Cooper Z, Delatte M Pharmacol Rev. 2024; 76(5):915-955.
PMID: 38849155 PMC: 11331953. DOI: 10.1124/pharmrev.123.001121.
Schwarz A, Kobeci D, Mancuso J, Moreno-Rodriguez V, Seekins C, Bui T J Pharmacol Exp Ther. 2024; 391(2):214-221.
PMID: 38834356 PMC: 11493438. DOI: 10.1124/jpet.124.002212.
Cannabinol: History, Syntheses, and Biological Profile of the Greatest "Minor" Cannabinoid.
Maioli C, Mattoteia D, Amin H, Minassi A, Caprioglio D Plants (Basel). 2022; 11(21).
PMID: 36365350 PMC: 9658060. DOI: 10.3390/plants11212896.
Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research.
Caprioglio D, Amin H, Taglialatela-Scafati O, Munoz E, Appendino G Biomolecules. 2022; 12(8).
PMID: 36008978 PMC: 9406211. DOI: 10.3390/biom12081084.